Sofie Mohlin

1.4k total citations
33 papers, 1.0k citations indexed

About

Sofie Mohlin is a scholar working on Molecular Biology, Neurology and Cancer Research. According to data from OpenAlex, Sofie Mohlin has authored 33 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 14 papers in Neurology and 14 papers in Cancer Research. Recurrent topics in Sofie Mohlin's work include Cancer, Hypoxia, and Metabolism (14 papers), Neuroblastoma Research and Treatments (14 papers) and Adrenal and Paraganglionic Tumors (5 papers). Sofie Mohlin is often cited by papers focused on Cancer, Hypoxia, and Metabolism (14 papers), Neuroblastoma Research and Treatments (14 papers) and Adrenal and Paraganglionic Tumors (5 papers). Sofie Mohlin collaborates with scholars based in Sweden, United States and Finland. Sofie Mohlin's co-authors include Sven Påhlman, Caroline Wigerup, Daniel Bexell, Emma U. Hammarlund, Kristoffer von Stedingk, Francesco Licausi, Emily Flashman, Martin Johansson, Esther Bridges and Darcy E. Wagner and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Advanced Materials.

In The Last Decade

Sofie Mohlin

32 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sofie Mohlin Sweden 17 431 351 208 206 169 33 1.0k
Piotr Rieske Poland 21 680 1.6× 255 0.7× 127 0.6× 312 1.5× 120 0.7× 88 1.3k
Yingqian Cai China 22 590 1.4× 263 0.7× 95 0.5× 98 0.5× 155 0.9× 45 1.2k
Sumithra Urs United States 17 704 1.6× 245 0.7× 62 0.3× 237 1.2× 141 0.8× 26 1.3k
Laura di Blasio Italy 18 583 1.4× 203 0.6× 60 0.3× 201 1.0× 126 0.7× 28 1.1k
Urs H. Langen United States 6 586 1.4× 135 0.4× 74 0.4× 169 0.8× 100 0.6× 6 1.3k
Angela Bentivegna Italy 21 724 1.7× 275 0.8× 59 0.3× 243 1.2× 176 1.0× 57 1.4k
Lea Scheppke United States 10 976 2.3× 474 1.4× 65 0.3× 161 0.8× 108 0.6× 13 1.5k
D. Feng United States 7 819 1.9× 345 1.0× 53 0.3× 277 1.3× 142 0.8× 10 1.3k
Yvonne A. Birney Ireland 17 511 1.2× 139 0.4× 127 0.6× 70 0.3× 145 0.9× 19 1.0k
Charles G. diPierro United States 17 982 2.3× 691 2.0× 97 0.5× 174 0.8× 174 1.0× 27 1.6k

Countries citing papers authored by Sofie Mohlin

Since Specialization
Citations

This map shows the geographic impact of Sofie Mohlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sofie Mohlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sofie Mohlin more than expected).

Fields of papers citing papers by Sofie Mohlin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sofie Mohlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sofie Mohlin. The network helps show where Sofie Mohlin may publish in the future.

Co-authorship network of co-authors of Sofie Mohlin

This figure shows the co-authorship network connecting the top 25 collaborators of Sofie Mohlin. A scholar is included among the top collaborators of Sofie Mohlin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sofie Mohlin. Sofie Mohlin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Amend, Sarah R., et al.. (2025). Chemical profiling of surviving cancer cells using ToF-SIMS and MCR analysis discriminates cell components. Analytical Methods. 17(10). 2263–2272. 1 indexed citations
2.
Liaño-Pons, Judit, et al.. (2025). Combined targeting of PRDX6 and GSTP1 as a potential differentiation strategy for neuroblastoma treatment. Proceedings of the National Academy of Sciences. 122(25). e2427211122–e2427211122.
3.
García, Alejandro García, Agatheeswaran Subramaniam, Sofie Mohlin, et al.. (2025). Compositional editing of extracellular matrices by CRISPR/Cas9 engineering of human mesenchymal stem cell lines. eLife. 13. 1 indexed citations
4.
Mazariegos, Marina S., et al.. (2024). Cell types or cell states? An investigation of adrenergic and mesenchymal cell phenotypes in neuroblastoma. iScience. 27(12). 111433–111433. 3 indexed citations
5.
Mohlin, Sofie, et al.. (2023). The Concept of Cancer Stem Cells: Elaborating on ALDH1B1 as an Emerging Marker of Cancer Progression. Life. 13(1). 197–197. 8 indexed citations
6.
Robledo, Mercedes, Bo Wängberg, Frida Abel, et al.. (2023). Cytoplasmic HIF-2α as tissue biomarker to identify metastatic sympathetic paraganglioma. Scientific Reports. 13(1). 11588–11588. 2 indexed citations
7.
Hammarlund, Emma U., Emily Flashman, Sofie Mohlin, & Francesco Licausi. (2020). Oxygen-sensing mechanisms across eukaryotic kingdoms and their roles in complex multicellularity. Science. 370(6515). 85 indexed citations
8.
Arbajian, Elsa, Mattias Aine, Anna Karlsson, et al.. (2020). Methylation Patterns and Chromatin Accessibility in Neuroendocrine Lung Cancer. Cancers. 12(8). 2003–2003. 4 indexed citations
9.
Hagerling, Catharina, Caroline Bergenfelz, Eva Källberg, et al.. (2020). Inflammatory macrophage derived TNFα downregulates estrogen receptor α via FOXO3a inactivation in human breast cancer cells. Experimental Cell Research. 390(1). 111932–111932. 8 indexed citations
10.
Mohlin, Sofie, et al.. (2019). Maintaining multipotent trunk neural crest stem cells as self-renewing crestospheres. Developmental Biology. 447(2). 137–146. 14 indexed citations
11.
Mohlin, Sofie, Karin Hansson, Sonia Martı́nez, et al.. (2019). Anti‐tumor effects of PIM / PI 3K/ mTOR triple kinase inhibitor IBL ‐302 in neuroblastoma. EMBO Molecular Medicine. 11(8). e10058–e10058. 29 indexed citations
12.
Stedingk, Kristoffer von, Toshitsugu Fujita, C. Persson, et al.. (2018). Promoter-associated proteins of EPAS1 identified by enChIP-MS – A putative role of HDX as a negative regulator. Biochemical and Biophysical Research Communications. 499(2). 291–298. 11 indexed citations
13.
Mohlin, Sofie & Laura Kerosuo. (2018). In Vitro Maintenance of Multipotent Neural Crest Stem Cells as Crestospheres. Methods in molecular biology. 2002. 1–11. 5 indexed citations
14.
Mohlin, Sofie, Caroline Wigerup, Annika Jögi, & Sven Påhlman. (2017). Hypoxia, pseudohypoxia and cellular differentiation. Experimental Cell Research. 356(2). 192–196. 44 indexed citations
15.
Påhlman, Sven & Sofie Mohlin. (2017). Hypoxia and hypoxia-inducible factors in neuroblastoma. Cell and Tissue Research. 372(2). 269–275. 63 indexed citations
16.
Allaoui, Roni, Caroline Bergenfelz, Sofie Mohlin, et al.. (2016). Cancer-associated fibroblast-secreted CXCL16 attracts monocytes to promote stroma activation in triple-negative breast cancers. Nature Communications. 7(1). 13050–13050. 145 indexed citations
17.
Mohlin, Sofie, Kristoffer von Stedingk, Esther Bridges, et al.. (2015). PI3K–mTORC2 but not PI3K–mTORC1 Regulates Transcription of HIF2A/EPAS1 and Vascularization in Neuroblastoma. Cancer Research. 75(21). 4617–4628. 76 indexed citations
18.
Agarwal, Shruti, Julhash U. Kazi, Sofie Mohlin, Sven Påhlman, & Lars Rönnstrand. (2014). The activation loop tyrosine 823 is essential for the transforming capacity of the c-Kit oncogenic mutant D816V. Oncogene. 34(35). 4581–4590. 14 indexed citations
19.
Mohlin, Sofie, et al.. (2013). HIF2A and IGF2 Expression Correlates in Human Neuroblastoma Cells and Normal Immature Sympathetic Neuroblasts. Neoplasia. 15(3). 328–IN38. 40 indexed citations
20.
Sun, Jianmin, Sofie Mohlin, Alicia Lundby, et al.. (2013). The PI3-kinase isoform p110δ is essential for cell transformation induced by the D816V mutant of c-Kit in a lipid-kinase-independent manner. Oncogene. 33(46). 5360–5369. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Piotr Rieske Breakdown of academic impact, for papers by Yingqian Cai Breakdown of academic impact, for papers by Sumithra Urs Breakdown of academic impact, for papers by Laura di Blasio Breakdown of academic impact, for papers by Urs H. Langen Breakdown of academic impact, for papers by Angela Bentivegna Breakdown of academic impact, for papers by Lea Scheppke Breakdown of academic impact, for papers by D. Feng Breakdown of academic impact, for papers by Yvonne A. Birney Breakdown of academic impact, for papers by Charles G. diPierro
Rankless by CCL
2026